Antimicrobial articles and method of manufacture

Details for Australian Patent Application No. 2007319586 (hide)

Owner 3M Innovative Properties Company

Inventors Burton, Scott A.; Holm, David R.

Agent Davies Collison Cave

Pub. Number AU-A-2007319586

PCT Pub. Number WO2008/060795

Priority 60/966,531 18.10.06 US; 61/007,931 18.10.06 US

Filing date 16 October 2007

Wipo publication date 22 May 2008

International Classifications

A61K 33/38 (2006.01) Medicinal preparations containing inorganic active ingredients - Silver

A61L 15/00 (2006.01) Chemical aspects of bandages, dressings, or absorbent pads or use of materials for their realisation

A61L 26/00 (2006.01) Chemical aspects of, or use of materials for, liquid bandages

A61L 31/00 (2006.01) Materials for other surgical articles

C09D 5/14 (2006.01) Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced - Paints containing biocides, e.g. fungicides, insecticides or pesticides

Event Publications

21 May 2009 PCT application entered the National Phase

  PCT publication WO2008/060795 Priority application(s): WO2008/060795

24 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007319590-Synthesis of selected stereoisomers of certain substituted alcohols

2007319580-Use of spiro-oxindole compounds as therapeutic agents